Dr. Matthew Garoufalis DPM, FASPS, FACPM, CWS, FFPM RCPS (Glasg), FRSM

Chief Medical Officer Advanced Oxygen Therapy Inc.

Dr. Garoufalis is a Past President of the American Podiatric Medical Association and is the Past President of the International Federation of Podiatrists. Dr. Garoufalis was a Senior Attending and the former Podiatric Surgery Residency Director at the Jesse Brown VA Medical Center and was also an Attending Physician at Hines VA Medical Center. He is a Life Member of the Association of Military Surgeons of the United States and is a current member of the International Association of Diabetic Foot Surgeons. He has a private practice in Chicago and is part of the Advent and University of Chicago Health System. Dr. Garoufalis is Board Certified by the American Board of Podiatric Surgery and American Board of Podiatric Medicine with Added Qualification in Wound Care and Limb Preservation. He is a Founding Fellow of American Society of Podiatric Surgeons and a Fellow of American College of Podiatric Medicine. Dr. Garoufalis is a Fellow of the Faculty of Podiatric Medicine of the Royal College of Physicians and Surgeons of Glasgow, and a Fellow of the Royal Society of Medicine. Dr. Garoufalis is also the Co-Chair of the Alliance of Wound Care Stakeholders. Dr. Garoufalis is currently the President of the American Board of Podiatric Medicine – International, and the Chief Medical Officer for Advanced Oxygen Therapy, Inc. He is a noted, award winning researcher and author of many articles and, as an invited speaker, has accepted speaking engagements for educational lectures, seminars, and workshops, both nationally and internationally, on a variety of topics pertinent to wound care, limb salvage, podiatric medicine and surgery, and practice management. He is considered a Key Opinion Leader in many areas.

Conference Day One: July 23, 2024

1:30 PM REDUCING AMPUTATIONS AND IMPROVING PAVE OUTCOMES FOR ALL VETERANS UTILIZING CYCLICALLY PRESSURIZED TOPICAL WOUND OXYGEN (TWO2) THERAPY

Major and Minor DFU related amputations continue to rise globally. The Veterans Administration’s PAVE program is intended to prevent or delay amputations for veterans at risk of limb loss. Evidence based wound care therapeutics proven to heal DFUs more durably are now available. The American Diabetes Association (ADA) awarded topical oxygen therapy an “A” grade treatment recommendation in their 2023 and 2024 Standards of Care. Additionally, the International Working Group on the Diabetic Foot (IWGDF) and Wound Healing Society (WHS) has also recommended its use in their latest clinical practice guidelines. Multiple RCT & RWE studies conducted within the Veterans Administration have demonstrated that AOTI’s unique cyclically pressurized patient applied at home TWO2 therapy heals DFUs more sustainably. These studies showed TWO2 healed DFUs with a six-fold reduction in recurrence, resulting in an 88% reduction in hospitalizations & 71% reduction in amputations over 12 months. 

Check out the incredible speaker line-up to see who will be joining Matthew.

Download The Latest Agenda